baber/WOPTO huggingface dataset:
Patent NZ-594199-A (NZ)
Title: Method of producing ethanol
Inventor: MEDOFF MARSHALL
IPC: C10J1/00
Filed: 2010-01-08
Abstract: Disclosed a method of making ethanol, the method comprising: treating biomass to reduce its recalcitrance, thereby producing treated biomass; contacting a portion of the treated biomass with a microorganism or with a mixture of microorganisms, wherein the microorganism or the mixture of microorganisms metabolise both sugar and syngas feedstocks, thereby converting said portion into acetic acid, acetate ester, acetate salt, or a mixture of any of the foregoing; thermochemically converting a second portion of the treated biomass to a syngas feedstock comprising hydrogen and carbon monoxide; providing a portion of the syngas feedstock to the microorganism or the mixture of microorganisms during step b); combining the acetic acid, acetate ester, acetate salt or the mixture of any of the foregoing with the hydrogen or the carbon monoxide under reactive conditions to produce ethanol; and isolating the ethanol.
Patent NZ-595660-A (NZ)
Title: Therapeutic applications in the cardiovascular field of quinazolinedione derivatives
Inventor: JANIAK PHILIP
IPC: C07D211/58
Filed: 2010-04-07
Abstract: Disclosed is the use of compounds of formula (I) for the preparation of medicaments intended for the treatment of at least one cardiovascular disease and/or to prevent the appearance of at least one cardiovascular disease. Examples of compounds of formula (I) are: 2-{ [3-(3,4-dimethoxybenzyl)-1-(1-formylpiperidin-4-yl)-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-6-yl]oxy} propanenitrile; 1-(1-acetylpiperidin-4-yl)-3-(3,4-dimethoxybenzyl)-6-hydroxyquinazoline-2,4(1H,3H)-dione and { [1-(1-acelylpiperidin-4-yl)-3-(3,4-dimethoxybenzyl)-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-6-yl]oxy} acetonitrile.
Patent NZ-600169-A (NZ)
Title: Method of making a decorative laminate with a core having an epoxy resin impregnated fibreboard sheet
Inventor: O'BRIAN KEVIN FRANCIS
IPC: B32B27/06
Filed: 2012-01-20
Abstract: Disclosed is a method of making a decorative laminate. The method includes providing at least one epoxy resin impregnated fiberboard sheet to form a core; placing at least one decorative layer adjacent to the core; and applying heat and pressure to the decorative layer and core in an amount sufficient to cure and form a decorative laminate. The density of the core of the decorative laminate ranges from about 1.15 g/cm 3 to about 1.35 g/cm 3 wherein the decorative laminate defines a flexural strength in the range of from about 110 to about 130 MPa under ISO 178.
Patent NZ-600756-A (NZ)
Title: Micronutrient fortification process and its uses
Inventor: MITTAL VIKAS ASHOK
IPC: A23L5/20
Filed: 2012-06-20
Abstract: Patent No. 600756 Disclosed is a mineral - protein complex, the complex including a mineral and a protein characterised in that the protein is derived from a milk source and wherein the milk source has a ratio of protein to calcium is equal to or above 45:1, and wherein the mineral-protein complex includes over 1% w/w mineral bound to the protein.
Patent NZ-600876-A (NZ)
Title: Electrical substation fault monitoring and diagnostics
Inventor: YARDIBI TARIK
IPC: H02B7/00
Filed: 2012-06-25
Abstract: Disclosed is a fault monitoring system for an electrical substation (54). The system is comprised of one or more arrays of acoustic sensors (52) placed around a substation boundary and processing circuitry configured to localise and identify faults in the substation (54). The one or more arrays of acoustic sensors (52) are configured to measure acoustic pressure waves. The processing circuitry is comprised of a sound source localisation module, a beamforming module and a component signature classification module. The sound source localisation module identifies an area of a sound source based on the acoustic pressure waves. The beamforming module provides enhanced acoustic pressure waves by eliminating background noise and an interfering noise from the acoustic pressure waves. The component signature classification module compares the enhanced acoustic pressure waves with component signatures to classify the acoustic pressure waves into various events to detect faults in the electrical substation (54).
Patent NZ-603654-A (NZ)
Title: Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
Inventor: KAUFMAN MICHAEL D
IPC: A01N43/90
Filed: 2009-10-29
Abstract: Disclosed herein are compounds of formula Ia, wherein the variables are defined in the specification. Compounds of the present invention find utility in the treatment of mammalian cancers and especially human cancers including, but not limited to, malignant melanomas, solid tumors, glioblastomas, ovarian cancer, pancreatic cancer, prostate cancer, lung cancers, breast cancers, kidney cancers, hepatic cancers, cervical carcinomas, metastasis of primary tumor sites, myeloproliferative diseases, chronic myelogenous leukemia, leukemias, papillary thyroid carcinoma, non-small cell lung cancer, mesothelioma, hypereosinophilic syndrome, gastrointestinal stromal tumors, colonic cancers, ocular diseases characterized by hyperproliferation leading to blindness including various retinopathies, diabetic retinopathy, rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, mastocytosis, mast cell leukemia, and diseases caused by PDGFR-α kinase, PDGFR-β kinase, c-KIT kinase, cFMS kinase, c-MET kinase, and oncogenic forms, aberrant fusion proteins and polymorphs of any of the foregoing kinases. Specific embodiments of the compound of formula I include the following: N-(2-fluoro-4-(2-(1-methyl-1H-pyrazol-4-yl)pyridin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; N-(2,5-difluoro-4-(2-(1-methyl-1H-pyrazol-4-yl)pyridin-4-yloxy)phenylcarbamoyl)-2-(4-fluorophenyl)acetamide; and N-(5-chloro-2-fluoro-4-(2-(1-methyl-1H-pyrazol-4-yl)pyridin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide.
Patent NZ-604054-A (NZ)
Title: Systems and methods for data packet transmission
Inventor: KASZTENNY BOGDAN Z
IPC: H04L12/70
Filed: 2011-06-13
Abstract: Disclosed is a method of ensuring integrity of data transmitted in a data network. The method includes a sending intelligent electronic device (IED) calculating a first data integrity value based on a sending IED identification and a variable datum; the sending IED and a receiving IED being in electrical communication using the data network. The sending IED constructs a network packet comprising the first data integrity value and the variable datum wherein the first data integrity value is calculated based on the sending IED identification and the variable datum. The sending IED omits the sending IED identification from the network packet and the transmits the network data packet. The receiving IED receives the network packet comprising the first data integrity value and the variable datum. The receiving IED calculates a second data integrity value based on the sending IED identification and the received variable datum. The receiving IED then verifies the network packet by comparing the first data integrity value and the second data integrity value.
Patent NZ-613286-A (NZ)
Title: Antibody molecules which bind il-17a and il-17f
Inventor: ADAMS RALPH
IPC: A61K39/395
Filed: 2012-01-11
Abstract: Disclosed is a neutralising antibody which binds human IL-1 7A and human IL-17F having a light chain and a heavy chain wherein the variable domain of the light chain comprises the sequence AIQLTQSPSSLSASVGDRVTITCRADESVRTLMHWYQQKPGKAPKLLIYLVSNSEIGVPDRFSGSGSGTDFRLTISSLQPEDFATYYCQQTWSDPWTFGQGTKVEIK and the variable domain of the heavy chain comprises the sequence GFTFSDYNMA for CDR-H1, the sequence TITYEGRNTYYRDSVKG for CDR-H2 and the sequence PPQYYEGSIYRLWFAH for CDR-H3. Also disclosed is the use of such an antibody in the manufacture of a medicament for the treatment or prophylaxis of a pathological disorder that is mediated by IL-17A and/or IL-17F, or that is associated with an increased level of IL-17A and/or IL-17F.
Patent NZ-618316-A (NZ)
Title: Neutralizing prolactin receptor antibody mat3 and its therapeutic use
Inventor: LINDEN LARS
IPC: C07K16/28
Filed: 2012-05-31
Abstract: Disclosed is an antibody or antigen-binding fragment thereof which antagonises prolactin receptor-mediated signalling, whereby the antibody or antigen-binding fragment thereof comprises a variable heavy chain containing the CDR sequences of FSSYWMHW, SDIARLSSYTNYADSVKGR, and ARGLDARRMDY and a variable light chain containing the CDR sequences of TGSSSNIGAGYVVH, RNNQRPS, and CAAWDDSLNGWL. Also disclosed is the use of the above-described antibody or antigen-binding fragment in preparation of a medicament for the treatment and/or prevention of endometriosis and adenomyosis, benign breast disease and mastalgia, or anti-oestrogen-resistant breast cancer.
Patent NZ-623781-A (NZ)
Title: Meditopes and meditope-binding antibodies and uses thereof
Inventor: WILLIAMS JOHN C
IPC: C07K16/00
Filed: 2012-04-10
Abstract: Discloses an isolated meditope-enabled antibody or fragment thereof, comprising: a heavy chain variable (VH) region, a heavy chain constant region (CH) or portion thereof, a light chain variable (VL) region comprising a threonine, serine, or aspartate at position 40, a residue other than glycine at position 41, a residue other than phenylalanine at position 83, and an aspartate or asparagine at position 85, according to Kabat numbering, and a light chain constant region (CL) or portion thereof, wherein the meditope-enabled antibody is a meditope-enabled variant of a human or humanised template antibody, which variant contains a plurality of framework region (FR) modifications, according to Kabat numbering, compared to the template antibody, said FR modifications being only at positions selected from the group consisting of positions 8, 9, 10, 38, 39, 40, 41, 42, 43, 44, 45, 82, 83, 84, 85, 86, 87, 99, 100, 101, 102, 103, 104, and 105 of the light chain of said template antibody, according to Kabat numbering, and positions 6, 9, 38, 39, 40, 41, 42, 43, 44, 45, 84, 86, 87, 88, 89, 90, 91, 103, 104, 105, 106, 107, 108, 109, and 110 of the heavy chain of said template antibody, according to Kabat numbering; and the meditope-enabled antibody or fragment binds to a meditope comprising a peptide of SEQ ID NO: 1, via a meditope binding site, wherein the sequence is as defined in the compete specification.
Patent NZ-627452-A (NZ)
Title: An unmanned water craft
Inventor: GRAEME PEDERSEN
IPC: A01K91/02
Filed: 2013-08-21
Abstract: An unmanned water craft 1 having sensing means 13, which, when activated senses whether the craft 1 is water borne and, when it senses that the craft 1 is water borne, the sensor 13 causes a power means 8 to power the craft 1 over or through the water. The craft carries a fishing line and is in use for fishing.
Patent NZ-631443-A (NZ)
Title: Nutritionally balanced food or beverage product
Inventor: POPE-MAYELL GUY WILLIAM CLAYTON
IPC: A23L2/38
Filed: 2012-03-13
Abstract: Disclosed is a process for manufacturing a food or beverage product which is based upon the nutritional reference values (NRV) as a starting point and which has the macronutrients of protein, carbohydrate and fat all balanced with respect to their relative percentage of the NRV and has fibre present in an amount which exceeds the relative percentage of the NRV to which the aforementioned macronutrients are matched, the process comprising the steps of: (i) selecting a percentage of the NRV that will be used to determine the amount of protein, carbohydrate and fat in the product, from any one of the following documents: Daily Reference Values given in USFDA Code of Federal Regulations 21 CFR 101.9, 1996; - % Daily Intake reference values given in the Australia New Zealand Food Standards; - GDA –Guideline Daily Amounts as published by the Food and Drink Federation, UK; - Reference Standards given in The Canadian Food and Drug Regulations and amendments; all as published on 13 March 2012; (ii) combining the protein, carbohydrate, fat macronutrients in amounts that accord to the selected percentage of the NRV so that each complete serving of the product has substantially the same percentage of the NRV; and (iii) adding fiber to the product so that a complete serving of the product provides fiber in a proportion of the NRV that is at least 5% greater than the percentage of the NRV provided by the fat, protein or carbohydrate in a serving.
Patent NZ-708065-A (NZ)
Title: Novel mucosal adjuvants and delivery systems
Inventor: PUMFORD NEIL
IPC: C07H15/04
Filed: 2013-10-29
Abstract: Adjuvants comprising chitosan cross-linked with, an aldehyde or mannosylated chitosan are provided herein. Methods of making the adjuvants and methods of combining or linking the adjuvants with antigens are also provided. The adjuvant-antigen combinations can be used in vaccine formulations and the vaccine formulations can be used, in methods to vaccinate animals against the source of the antigen or to enhance the immune response in a subject. A particular embodiment of the invention is a vaccine formulation comprising a microbial antigen and an adjuvant composition, the adjuvant composition comprising an open ring mannose moiety linked to chitosan to form a Schiff base, wherein the Schiff base is not reduced.
Patent NZ-710290-A (NZ)
Title: Improvements in square balers
Inventor: VERHAEGHE DIDIER
IPC: A01F15/08
Filed: 2014-02-10
Abstract: A square baler is disclosed which comprises a baling chamber, a plunger reciprocable at one end of the baling chamber, and a pre-compression chamber within which charges of crop are amassed and pre-compressed by a rotor prior to transfer into the baling chamber. The baler also includes a pickup roller having radially projecting tines for picking up crop from the ground and advancing the crop to the rotor. A transducer is provided for producing an electrical output signal indicative of the load on the rotor and a processor is operative to estimate the rate of crop flow into the pre-compression chamber by analysing the output signal of the transducer over a complete filling and emptying cycle of the pre-compression chamber. The estimated crop flow rate into the pre-compression chamber may be used to ensure that the crop density attains a desired level at the time that it is transferred into the baling chamber.
Patent NZ-710816-A (NZ)
Title: A post mounting system and apparatus
Inventor: O’TOOLE LAWRENCE
IPC: E01F9/669
Filed: 2014-02-24
Abstract: Known fixing methods for fixing a device to a hole in a flange of a fence post can result in a loose fitting attachment. Accordingly, disclosed is an apparatus 10 for connection to a flange 52 of a post 50. The flange 52 comprises two or more elongated apertures 54 therethrough which are spaced out along the length of the flange. The apparatus comprises a body 12 from which there extends two sets of projections 14A&B and 16A&B. Each projection in each set respectively extends from the body to a distal end 18. Each of the sets 14, 16 comprises two projections A&B which extend from the body so as to define a recess R therebetween which is configured to receive the flange 52 therein. The distal ends 18 of the two projections 14 or 16 in a given set are able to locate in adjacency of a respective one of the elongated apertures 54 in the flange. At least one of the distal ends of at least one the projections comprises a passage 20 formed thereat. The passage 20 has a profile configured in a similar manner to that of the flange elongated aperture 54 adjacent to which it can be located in use. This similar configuring of the passage 20 can facilitate mounting of the projection to the elongated aperture 54 (e.g. it can make optimal use of the elongated aperture to enhance mounting of the apparatus to the post). A respective pin 32A, 32B is provided for each of the projections. The pins are connected together by a bridging member 34. When the passage 20 is located in adjacency of a respective flange aperture 54, the pins 32A, 32B are each able be inserted through a respective passage 20 aligned with a respective aperture 54 to secure the apparatus 10 to the post. The bridging member 34 can maintain one pin in a fixed orientation relative to the other pin to aid in reliable insertion of the pins 32A and 32B (i.e. both pins may be readily lined up with their respective passages 20).
Patent NZ-710838-A (NZ)
Title: Analyte detection devices, multiplex and tabletop devices for detection of analytes, and uses thereof
Inventor: SICILIANO NICHOLAS A
IPC: G01N33/543
Filed: 2012-01-27
Abstract: A device for detecting an analyte, within a sample, comprising a housing member. The housing member comprising an inlet, a force member (2070), a moveable locking member (2065), an analyte detection membrane system (2047), an attachment member (2066), and a channel system (2300). The inlet allows a sample to be added into the system for testing and connects with the channel system (2300). The force member (2070) provides a compressing force to the analyte detection membrane system (2047). The moveable locking member (2065) maintains the force member against the membrane system until the sample is ready for testing. The locking system may be activated to release the force member and remove the compressing force from the membrane system. The analyte detection membrane system (2047) comprises a conjugate pad, a permeable membrane, a test membrane and an absorbent member. The membrane system may be arranged with each layer stacked one on top of the other such that the fluid from the channel system may flow through each layer in order. The attachment member (2066) may be attached to the moveable locking member (2065) and the conjugate pad (2050) such that the conjugate pad may be removed from the membrane system when the locking member is actuated. Removal of the conjugate pad can expose the test membrane underneath. The device may comprise multiple membrane systems each arranged to test for a different analyte, the channel system may comprise multiple channels for directing a portion of the sample to each membrane system. The device may be particularly useful for detecting a food-borne pathogen such as E. coli, Listeria, Campylobacter or Salmonella.
Patent NZ-713673-A (NZ)
Title: Energy absorbing apparatus
Inventor: DIEHL ANDREW KARL
IPC: F16F7/12
Filed: 2022-07-22
Abstract: A self retracting lifeline device comprises a line connected to an energy absorbing member, which when the velocity at which the line is withdrawn from the device is above a certain speed, the member absorbs the kinetic energy from the line by being drawn through a die and so applies a retarding force to the line. The device has an inherent reliability since it is mechanically simple and relies on known and predictable properties of the materials used.
Patent NZ-716125-A (NZ)
Title: Organic waste processing
Inventor: PALMER BRUCE WILLIAM
IPC: C05F3/00
Filed: 2014-06-19
Abstract: The present invention relates to methods of processing organic waste, in particular it relates to a method for making fertiliser from organic waste, especially slow release fertiliser. The present invention also relates to fertilisers made by the method of the invention, especially slow release fertiliser. The method of processing organic waste to provide a slow-release fertiliser may comprise at least one hydrolysis step to provide hydrolysed organic waste and a setting step to provide a slow release fertiliser.
Patent NZ-727412-A (NZ)
Title: Methods of treating neurodevelopmental diseases and disorders
Inventor: CHEUNG STEVE
IPC: A61K31/20
Filed: 2015-06-05
Abstract: The present invention relates generally to methods for the treatment and/or prophylaxis of neurological diseases and disorders involving administration of trans 10-HDA. In particular, the methods of the present invention are useful in the treatment and/or prophylaxis of acquired or progressive neurodevelopmental disorders and conditions in mammals. More particularly, methods are taught herein for the treatment and/or prophylaxis of diseases and disorders such as autism spectrum disorders.
Patent NZ-735099-A (NZ)
Title: A mount assembly for engineering services
Inventor: THREADGOLD WILLIAM
IPC: F24F1/60
Filed: 2016-02-26
Abstract: The present disclosure relates to a mount assembly for engineering services such as air handling units (AHU) of a heating, ventilating, and air-conditioning (HVAC) systems. In one form, the mount assembly comprises an aperture comprising a female screw thread, and a resilient element comprising an item attachment point and a male screw thread adapted for threadable engagement with the female thread of the base so that the resilient element interposes the item attachment point and the-base. In the event of seismic activity causing vibration of the ground and the base in turn, the resilient element will elastically deform without failing, while absorbing at least some of this vibration, so that not all is transmitted to the attachment point.
Patent NZ-736675-A (NZ)
Title: Methods of treating epstein-barr virus-associated lymphoproliferative disorders by t cell therapy
Inventor: DOUBROVINA EKATERINA
IPC: A61K35/15
Filed: 2016-05-11
Abstract: Disclosed herein are methods of treating an EBV-LPD (Epstein-Barr Virus- associated lymphoproliferative disorder) in a human patient who has failed combination chemotherapy to treat the EBV-LPD and/or radiation therapy to treat the EBV-LPD, comprising administering to the human patient a population of allogeneic T cells comprising EBV-specific T cells.
Patent NZ-737423-A (NZ)
Title: Method for generating antibodies against t cell receptor
Inventor: SCHENDEL DOLORES
IPC: C07K16/28
Filed: 2016-06-01
Abstract: The invention relates to a method for generating an antibody binding to a cell surface protein of interest, the method comprising the following steps: (a) providing a non-human cell which does not express the endogenous form of the cell surface protein of interest but expresses an exogenous form of the cell surface protein of interest comprising at least one human segment; (b) immunization of a non-human animal with the cell line provided in step (a); (c) generation of hybridomas from the immunized non-human animal of step (b); (d) screening for an antibody that binds to the cell surface protein of interest by contacting the antibodies secreted by the hybridomas of step (c) with human cells which do not express the endogenous form of the cell surface protein of interest but express an exogenous form of the cell surface protein of interest comprising at least one human segment, wherein the cell surface protein of interest is at least one TCR receptor of interest and wherein the non-human animal is of another species than the non-human cell.
Patent NZ-738527-A (NZ)
Title: Nanoparticles for use as a therapeutic vaccine
Inventor: POTTIER AGNÈS
IPC: A61K9/00
Filed: 2016-05-27
Abstract: The present invention relates to the use of a nanoparticle and/or aggregate of nanoparticles for the production of a pharmaceutical in situ vaccine composition for the treatment of cancer in a subject suffering from metastatic cancer and undergoing a palliative radiotherapy, in a subject suffering from metastatic cancer for whom radiotherapy has been abandoned, in a subject suffering from a cancer which is not treated by radiotherapy, or in a subject suffering from a cancer affecting blood or lymphoid cell tissue, wherein the treatment comprises administering the vaccine composition to the subject, exposing the subject to a fractionated radiotherapy comprising at least one irradiation step wherein the ionizing radiations dose ranges from 1.8 to 20 Gray (Gy), and wherein each nanoparticle consists in Hafnium (IV) oxide (HfO2) or Rhenium (IV) oxide (ReO2), has a density of at least 7 g/cm3 and wherein each nanoparticle or aggregate of nanoparticles is covered with a biocompatible coating allowing the nanoparticle stability between pH 6.5 and 7.5 in a physiological fluid. The present invention also relates to kits comprising such a nanoparticle or aggregate of nanoparticles or vaccine compositions, together with at least one immunotherapeutic agent.